CNTNAP2 and autoimmune encephalitis: The subtlety likely relates to the relatively slow clinical progression of CASPR2 autoimmune encephalitis in humans compared to other encephalitides, and the absence of MRI, CSF and EEG changes in many cases(Benoit et al., 2023; Van Sonderen et al., 2016).